| 标题 |
Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts |
| 网址 | |
| DOI |
10.1016/j.ygyno.2026.02.004
doi
|
| 其它 |
期刊:Gynecologic Oncology 作者:Luca Palmieri; Stefania Bellone; Cem Demirkiran; Tobias M.P. Hartwich; Namrata Sethi; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)